Annual Revenue
$270.26 M
+$50.08 M+22.74%
31 December 2023
Summary:
Kiniksa Pharmaceuticals annual revenue is currently $270.26 million, with the most recent change of +$50.08 million (+22.74%) on 31 December 2023. KNSA annual revenue is now at all-time high.KNSA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$112.21 M
+$3.58 M+3.30%
30 September 2024
Summary:
Kiniksa Pharmaceuticals quarterly revenue is currently $112.21 million, with the most recent change of +$3.58 million (+3.30%) on 30 September 2024. Over the past year, it has increased by +$45.17 million (+67.37%). KNSA quarterly revenue is now at all-time high.KNSA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$384.10 M
+$45.17 M+13.33%
30 September 2024
Summary:
Kiniksa Pharmaceuticals TTM revenue is currently $384.10 million, with the most recent change of +$45.17 million (+13.33%) on 30 September 2024. Over the past year, it has increased by +$135.35 million (+54.41%). KNSA TTM revenue is now at all-time high.KNSA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNSA Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.7% | +67.4% | +54.4% |
| 3 y3 years | - | +827.8% | +1840.0% |
| 5 y5 years | - | - | - |
KNSA Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +601.2% | at high | +827.8% | at high | +1840.0% |
| 5 y | 5 years | at high | +601.2% | at high | +1356.6% | at high | +4885.7% |
| alltime | all time | at high | +601.2% | at high | +1356.6% | at high | +4885.7% |
Kiniksa Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $112.21 M(+3.3%) | $384.10 M(+13.3%) |
| June 2024 | - | $108.63 M(+36.0%) | $338.93 M(+12.3%) |
| Mar 2024 | - | $79.86 M(-4.2%) | $301.77 M(+11.7%) |
| Dec 2023 | $270.26 M(+22.7%) | $83.39 M(+24.4%) | $270.26 M(+8.6%) |
| Sept 2023 | - | $67.05 M(-6.2%) | $248.75 M(-11.4%) |
| June 2023 | - | $71.47 M(+47.8%) | $280.84 M(+18.8%) |
| Mar 2023 | - | $48.34 M(-21.9%) | $236.34 M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $220.18 M(+471.2%) | $61.88 M(-37.6%) | $220.18 M(+24.4%) |
| Sept 2022 | - | $99.14 M(+267.5%) | $177.04 M(+96.7%) |
| June 2022 | - | $26.97 M(-16.2%) | $90.00 M(+27.2%) |
| Mar 2022 | - | $32.19 M(+71.7%) | $70.73 M(+83.5%) |
| Dec 2021 | $38.54 M | $18.75 M(+55.0%) | $38.54 M(+94.7%) |
| Sept 2021 | - | $12.10 M(+57.0%) | $19.80 M(+157.0%) |
| June 2021 | - | $7.70 M | $7.70 M |
FAQ
- What is Kiniksa Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual revenue year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly revenue year-on-year change?
- What is Kiniksa Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals TTM revenue year-on-year change?
What is Kiniksa Pharmaceuticals annual revenue?
The current annual revenue of KNSA is $270.26 M
What is the all time high annual revenue for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual revenue is $270.26 M
What is Kiniksa Pharmaceuticals annual revenue year-on-year change?
Over the past year, KNSA annual revenue has changed by +$50.08 M (+22.74%)
What is Kiniksa Pharmaceuticals quarterly revenue?
The current quarterly revenue of KNSA is $112.21 M
What is the all time high quarterly revenue for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly revenue is $112.21 M
What is Kiniksa Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, KNSA quarterly revenue has changed by +$45.17 M (+67.37%)
What is Kiniksa Pharmaceuticals TTM revenue?
The current TTM revenue of KNSA is $384.10 M
What is the all time high TTM revenue for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high TTM revenue is $384.10 M
What is Kiniksa Pharmaceuticals TTM revenue year-on-year change?
Over the past year, KNSA TTM revenue has changed by +$135.35 M (+54.41%)